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Abstract
Benign metastasising leiomyoma (BML) is characterised by extrauterine smooth muscle tumours in women after surgical treat-
ment for uterine leiomyoma. Usually manifested as solitary or multiple focal lesions in various organs, it imposes a scrutinous dia-
gnostic work-up to exclude a malignant disease and requires confirmation in microscopic examination of the extrauterine focus. 
The authors present a case of a 56-year-old woman with BML manifesting as bilateral multiple pulmonary nodules, with a tenta-
tive diagnosis of a disseminated malignant disease of mesenchymal origin. 
The patient underwent multiple diagnostic tests, which excluded malignancy. The definite diagnosis was established after the 
microscopic reevaluation of an excised pulmonary nodule. The patient is monitored with chest magnetic resonance. 
BML should be considered in the differential diagnosis of multiple pulmonary nodules in asymptomatic women. Patients with 
BML require long-term monitoring, therefore the selected imaging method should not carry the risk of cumulative side effects. 
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Introduction
Uterine leiomyomas are one of the most 
common benign tumours in women affecting as 
many as 20–80% of females, depending on age 
and ethnicity [1, 2]. Besides benign leiomyomas 
and malignant leiomyosarcomas, uterine smooth 
muscle tumours include benign tumours with 
an unusual growth pattern, some of which may 
demonstrate metastatic potential [3, 4]. 
Benign metastasising leiomyoma (BML) is 
a rare entity characterised by the presence of smo-
oth muscle tumours of uterine origin in various 
organs. Although benign, its biological behaviour 
mimics that of a malignant tumour, therefore 
BML is a diagnostic pitfall. As the disease has 
extrauterine manifestation, patients with BML are 
rarely referred to gynecologists, but are diagnosed 
by other specialists or by general practitioners. 
The lungs are the most common site of BML 
involvement. Pulmonary BML lesions typically 
present as multiple nodules, which vary in size 
and usually show poor contrast enhancement 
in computed tomography. A  broad spectrum 
of diagnostic tests in search of a disseminated 
malignant disease is usually applied, however, 
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this diagnostic work-up is inconclusive and the 
definite diagnosis of BML is based on the micro-
scopic examination of the extrauterine tumour. 
Case report 
A never-smoking 56-year-old nulligravida 
was admitted to our department due to multiple 
pulmonary nodules detected in a routine chest 
radiograph performed because of newly diagno-
sed arterial hypertension. The patient denied 
any respiratory symptoms, loss of weight, fever 
or sweating. Her past medical history included 
hysterectomy due to uterine leiomyomas 15 years 
ago and left-sided oophorectomy due to an ovarian 
cyst 2 years ago. Prior to admission, she underwent 
multiple diagnostic tests in search of a dissemina-
ted malignancy. Computed tomography of the chest 
revealed the presence of multiple well-circumscri-
bed nodules varying in size with poor intravenous 
contrast enhancement in both lungs; no enlarged 
lymph nodes were detected. Positron emission 
tomography with fluorodeoxyglucose (18FDG-PET/
CT) was performed, however, no foci of increased 
metabolism were revealed in the chest or abdomen. 
Blood testing for cancer markers, including CA 
19-9, CA-125, CA 15-3, was negative. No data on 
bronchoscopy or the cytological examination of 
bronchial washing or bronchoalveolar lavage were 
available. The patient was referred for a diagnostic 
right-sided thoracotomy. Histopathological exami-
nation of the excised lung nodule revealed a smo-
oth muscle tumour with positive immunochemical 
reaction to vimentin, therefore a diagnosis of 
a disseminated malignant disease of mesenchymal 
origin was established. The patient was qualified 
for chemotherapy, however, she was referred to 
our department by her attending oncologist for 
reevaluation due to the discrepancy between the 
clinical presentation, results of the imaging studies 
and the histopathological diagnosis.
On admission, the patient was in a good ge-
neral state, physical examination did not reveal 
any abnormalities. The results of blood and urine 
laboratory investigations were within the normal 
range. The chest radiograph did not reveal new 
focal lesions in comparison to the radiograph 
performed 12 months ago; multiple nodules were 
seen in the middle and lower areas of both lungs, 
with no evident hilar enlargement (Fig. 1). Chest 
computed tomography also failed to show any 
new lesions when compared with the CT scans 
previously performed, the detected pulmonary 
nodules were well-circumscribed, showed poor 
contrast enhancement and the largest nodule 
Figure 1. Posteroanterior chest radiograph showing multiple, round 
nodules in the middle and lower fields of both lungs
had the diameter of 25 mm. The endoscopic 
appearance of the bronchial tree was normal, 
bronchial washing was negative for atypical cells 
and bacteria. The histopathologic slides from the 
specimen obtained in the earlier performed tho-
racotomy were referred to a reference oncology 
centre for reassessment. The microscopic exami-
nation showed plump spindle cells with vesicular 
nuclei with no atypia and perivascular location, 
which showed vimentin, smooth muscle actin 
and desmin expression. No necrosis or abnormal 
mitotic figures were found (Fig. 2). A comparison 
with the microscopic appearance of the uterine 
leiomyoma was not possible as we did not have ac-
cess to the material. Given the history of hysterec-
tomy due to leiomyomas, the clinical course, the 
presence of the nodules in imaging studies, lack 
of evidence for malignancy, the final diagnosis of 
benign metastasising leiomyoma was established. 
As the patient was asymptomatic, no treatment 
was offered, she has been monitored every 12–18 
months. Having demonstrated good agreement be-
tween the appearance of the BML lesions in chest 
CT and magnetic resonance (Fig. 3), the latter was 
selected as the imaging follow-up method to avoid 
excessive CT-related radiation exposure. 
The patient has been under our observation 
for 45 months. She remains asymptomatic and 
there is no evident progression of the disease in 
MR of the chest. 
Discussion
Benign metastasising leiomyoma is a  rare 
entity with more than 150 cases reported in the 
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Figure 2. Metastasising leiomyoma — representative histopathology of the pulmonary lesion shows plump spindle cells with vesicular nuclei. 
There is no atypia and no mitotic figures are detected (A — H&E, 400 ×). Immunohistochemistry (B — IHC) shows strong cytoplasmic stain with 
antibody against desmin (400 ×)
Figure 3. Corresponding sections (coronal plane) of chest computed tomography (A, B) and magneting resonance (C, D) showing good agreement 
in the imaging of the pulmonary nodules
A B
A B
C D
literature [3, 5]. At least two cases have been 
also described in the Polish literature. Jęda et al. 
[6] reported a 72-year-old woman, in whom an 
extrauterine BML lesion was found in the small 
intestine. The second case described by Radzi-
kowska et al. [7] presented with pulmonary BML 
metastases. 
BML occurs mainly in women in repro-
ductive age with a history of surgical treatment 
for uterine leiomyomas [2, 5]. BML foci may be 
detected from 3 months to even 30 years after 
hysterectomy or myomectomy [8, 9]. The lungs 
are the main site of involvement; BML is mostly 
manifested as multiple, well-circumscribed, 
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non-calcified nodules with poor contrast en-
hancement, but a miliary pattern has also been 
reported [10]. In some cases, BML pulmonary 
lesions were reported to show enhancement after 
contrast administration [7], which may further 
strengthen the suspicion of malignancy. In gene-
ral, the pulmonary nodules do not demonstrate 
an elevated FDG uptake in PET/CT. Some authors 
postulated that in leiomyomas with higher con-
centration of growth factors, increased glycogen 
levels in the endometrium of the leiomyoma-
tous uterus, and abundant vascularisation [11] 
an increased glucose metabolism may be seen. 
Therefore we may assume that FDG uptake may 
also be increased in BML foci, although, to the 
best of our knowledge, such a case has not been 
described to date. Although generally considered 
benign, some authors have suggested that BML 
should be classified as low grade leiomyosarcoma. 
There is a single report of a patient with BML, in 
whom a microscopic examination of an excised 
lung mass showed features of leiomyoma in the 
upper part of the lesion and leiomyosarcoma in 
the loweru. This was consistent with FDG uptake 
in PET/CT, which showed a polarised distribution 
within the mass, being much higher in its lower 
part [12]. The authors concluded that a malignant 
transformation of the pulmonary BML tumour 
could not be excluded. 
The diagnosis of BML must be confirmed in 
microscopic examination and therefore usually 
requires resection of an extrauterine tumour. In 
our patient, the pulmonary involvement was in-
cidentally detected 15 years after hysterectomy. 
The radiological appearance of the detected lesion 
was similar to that described in earlier reports on 
BML, and the definite final diagnosis was based 
on the microscopic examination of a pulmonary 
nodule excised in right-sided thoracotomy. Inte-
restingly, in the report by Radzikowska et al. [7], 
transbronchial lung biopsy was also feasible for 
the diagnosis of pulmonary BML involvement, 
what indicates that, in selected cases, open lung 
biopsy may be avoided. However, given the rarity 
of BML and the need to differentiate this con-
dition with a disseminated neoplastic disease, 
it seems that invasive diagnostic procedures are 
fully justified.
The pathogenesis of BML has not been ful-
ly elucidated. As in the vast majority of cases 
extrauterine foci are seen in patients after surgical 
treatment of uterine leiomyomas, most authors 
believe that surgical injury promotes hemato-
genous spread of the tumour. The intravascular 
presence of the tumor cells may also be the result 
of necrosis or rupture within the primary focus in 
the uterus, which may explain the extrauterine 
expansion in patients who had not been operated 
[2]. Analogically, BML may spread by lymphatic 
circulation. Other hypotheses include the deve-
lopment of BML from circulating stem cells or 
from the metaplastic coelomic transformation, 
probably enhanced by estrogen replacement 
therapy in women after surgical castration [13].
Given the low incidence of BML, no treat-
ment guidelines have been established to date. 
The prognosis is good, most of the patients remain 
asymptomatic, however, in some cases tumour 
growth may cause a significant deterioration of 
health status. Treatment should be offered when 
the extrauterine tumours tend to grow or cause 
organ-specific symptoms. In most of the repor-
ted cases, only monitoring or surgical resection 
have been applied, however, surgical treatment 
cannot be considered in patients with multiple 
lesions. The extrauterine tumours express estro-
gen and progesterone receptors (similarly to the 
primary uterine focus), therefore treatment with 
luteinizing-hormone releasing hormone agonists 
or oophorectomy has also been offered [14, 15]. 
Other treatment options include selective estro-
gen receptor modulators (tamoxifen, raloxifene) 
and aromatase inhibitors [13]. In our patient, the 
lung nodules were detected incidentally and the 
disease was clinically indolent, so only observa-
tion was offered. She has remained asymptoma-
tic and neither the size nor the number of the 
lung nodules had increased over the 45 months 
of follow-up. We selected magnetic resonance as 
the imaging method for monitoring for several 
reasons. Firstly, computed tomography is related 
with a  significant radiation exposure, which 
may increase cancer risk [16]. Secondly, MR 
has a relatively good sensitivity for pulmonary 
nodule detection — 80-90% for nodules with 
a diameter of 3–4 mm and 100% for nodules > 
8 mm [17]. This was confirmed by a group of 
Polish authors, who reported an 80% overall MRI 
sensitivity for lung nodule detection; for nodules 
> 8 mm MRI sensitivity also reached 100% [18]. 
The same authors demonstrated a good agreement 
between CT and MRI in the estimation of nodule 
size. Therefore, it seems that MRI is an attractive 
option for long-term follow-up of pulmonary 
nodules with a high probability of benign cha-
racter. In our opinion, the choice of MRI for 
further monitoring in our case was justified. As 
the monitoring methods were not mentioned in 
most of the previously published case reports, 
we believe that our report may be the first to 
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show the usefulness of chest MR in monitoring 
BML patients with lung involvement. 
Conclusion
Benign metastasising leiomyoma is a benign 
disease with a metastatic potential. Extrauterine 
tumours usually occur in patients with a history 
of uterine leiomyomas treated with hysterectomy 
or myomectomy. The definite diagnosis is challen-
ging and requires confirmation in histopathologic 
evaluation. Surgical treatment may be offered to 
patients with solitary tumours; treatment options 
include hormonal therapy, selective estrogen re-
ceptor modulators and oophorectomy. In asymp-
tomatic patients, careful monitoring may be ap-
plied; in patients with pulmonary involvement, 
chest MR may be a better choice than CT owing 
to CT-related radiation exposure. Although some 
patients may require intervention due to tumour 
growth, the prognosis is good.
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